Report of Foreign Issuer (6-k)
2014年11月14日 - 12:33AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND
EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of 1934
November, 2014
Commission File Number 0-26005
MICROMEM TECHNOLOGIES INC.
121 Richmond Street West, Suite 304, Toronto, ON M5H 2K1
[Indicate by checkmark whether the
registrant files or will file annual reports under cover Form 20-F or Form
40-F.]
Form 20-F [X]
Form 40-F [ ]
[Indicate by check mark whether
the registrant by furnishing the information contained in this Form is also
thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b)
under the Securities Exchange Act of 1934.]
Yes [ ]
No [X]
[If "Yes"
is marked, indicate below the file number assigned to the registrant in
connection with rule 12g3-2(b): N/A
This report on Form 6-K is hereby incorporated by reference
in the registration statement on Form F-3 (Registration No. 333-134309) of
Micromem Technologies Inc. and in the prospectus contained therein, and this
report on Form 6-K shall be deemed a part of such registration statement from
the date on which this report is filed, to the extent not superseded by
documents or reports subsequently filed or furnished by Micromem Technologies
Inc. under the Securities Act of 1933 or the Securities Exchange Act of 1934.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.
|
|
|
MICROMEM TECHNOLOGIES INC. |
|
|
|
By:
/s/ Joseph Fuda |
Date: November 13, 2014 |
Name: Joseph Fuda |
|
Title: Chief Executive Officer |
Exhibit Index
FOR IMMEDIATE RELEASE |
November 13, 2014 |
Micromem and American based Oil Company Execute Second
Agreement
Toronto, New York, November 13, 2014: Micromem
Technologies Inc. (Micromem) (CSE: MRM, OTCQX: MMTIF) through its wholly owned
subsidiary Micromem Applied Sensor Technologies Inc. (MAST) is pleased to
announce it has executed a Joint Product Development Agreement (the Agreement)
for $1,800,000 USD. In addition to work already underway over the last year, the
new Agreement moves this project from the development phase to the
pre-production phase. This is in addition to and parallel with the originally
executed agreement announced on August 2, 2013. The contracted scope of work
involves application of MASTs patented sensor platform technology and
innovative use of MASTs engineered nanoparticles in oil and gas production.
Earlier this year MAST successfully completed the contracted
scope of work associated with developing the Proof of Concept nanotechnology
solutions. This milestone triggers a payment of $704,000 US to Micromem in
addition to $196,000 US already received.
The principal objective outlined in the Agreement would have
MAST provide the client with the next phase deliverable, a pre-manufacturing
solution and ready for initial field trials.
Further details on specifics of the projects, types of
solutions and expected deployment are still subject to Non-Disclosure at this
time.
About Micromem and MASTInc
MASTInc is a wholly owned U.S.-based subsidiary of Micromem
Technologies Inc., a publicly traded (OTCQX: MMTIF, CSE: MRM) company. MASTInc
analyzes the specific industry sectors to create intelligent game-changing
applications that address unmet market needs. By leveraging its expertise and
experience with sophisticated magnetic sensor applications, MASTInc successfully
powers the development and implementation of innovative solutions for
healthcare/biomedical, natural resource exploration, government, information
technology, manufacturing, and other industries. Visit www.micromeminc.com www.mastinc.com.
Safe Harbor Statement
This press release contains forward-looking statements. Such
forward-looking statements are subject to a number of risks, assumptions and
uncertainties that could cause the Companys actual results to differ materially
from those projected in such forward-looking statements. In particular, factors
that could cause actual results to differ materially from those in forward
looking statements include: our inability to obtain additional financing on
acceptable terms; risk that our products and services will not gain widespread
market acceptance; continued consumer adoption of digital technology; inability
to compete with others who provide comparable products; the failure of our
technology; the infringement of our technology with proprietary rights of third
parties; inability to respond to consumer and technological demands; inability
to replace significant customers; seasonal nature of our business; and other
risks detailed in our filings with the Securities and Exchange Commission.
Forward-looking statements speak only as of the date made and are not guarantees
of future performance. We undertake no obligation to publicly update or revise
any forward-looking statements. When used in this document, the words believe,
expect, anticipate, estimate, project, plan, should, intend,
may, will, would, potential, and similar expressions may be used to
identify forward-looking statements.
The CSE or any other securities regulatory authority has not
reviewed and does not accept responsibility for the adequacy or accuracy of this
press release that has
been prepared by management.
Listing: NASD OTCQX-Bulletin Board - Symbol:
MMTIF
CSE
- Symbol: MRM
Shares issued: 188,436,724
SEC File No: 0-26005
Investor Contact: info@micromeminc.com; Tel. 416-364-2023
Subscribe to receive News Releases by Email on our websites home page.
www.micromeminc.com
CS Diagnostics (PK) (USOTC:FZRO)
過去 株価チャート
から 8 2024 まで 9 2024
CS Diagnostics (PK) (USOTC:FZRO)
過去 株価チャート
から 9 2023 まで 9 2024